{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,21]],"date-time":"2026-11-21T22:11:21Z","timestamp":1795299081644,"version":"4.10.3"},"reference-count":245,"publisher":"BMJ","issue":"11","funder":[{"name":"Gastroenterological Society of Taiwan","award":["Not applicable."],"award-info":[{"award-number":["Not applicable."]}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"crossref","award":["Not applicable."],"award-info":[{"award-number":["Not applicable."]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Ministry of Health and Welfare of Taiwan","award":["MOHW114-TDU-B-211-124001"],"award-info":[{"award-number":["MOHW114-TDU-B-211-124001"]}]},{"DOI":"10.13039\/501100020950","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["112-2314-B-002-280-MY3"],"award-info":[{"award-number":["112-2314-B-002-280-MY3"]}],"id":[{"id":"10.13039\/501100020950","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004532","name":"Japan International Cooperation Agency","doi-asserted-by":"crossref","award":["Not applicable."],"award-info":[{"award-number":["Not applicable."]}],"id":[{"id":"10.13039\/501100004532","id-type":"DOI","asserted-by":"crossref"}]},{"name":"The Liver Disease Prevention & Treatment Research Foundation","award":["Not applicable."],"award-info":[{"award-number":["Not applicable."]}]},{"name":"Australian Federal Government to the St George and Sutherland Medical Research Foundation","award":["Not applicable."],"award-info":[{"award-number":["Not applicable."]}]},{"DOI":"10.13039\/501100005762","name":"National Taiwan University Hospital","doi-asserted-by":"publisher","award":["Not applicable."],"award-info":[{"award-number":["Not applicable."]}],"id":[{"id":"10.13039\/501100005762","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Gut"],"accepted":{"date-parts":[[2025,7,1]]},"published-print":{"date-parts":[[2025,11]]},"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>\n                      To convene a global consensus on\n                      <jats:italic>Helicobacter pylori<\/jats:italic>\n                      (\n                      <jats:italic>H pylori<\/jats:italic>\n                      ) screening and eradication strategies for gastric cancer prevention, identify key knowledge gaps and outline future research directions.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      32 experts from 12 countries developed and refined consensus statements on\n                      <jats:italic>H pylori<\/jats:italic>\n                      management, using the Grading of Recommendations Assessment, Development and Evaluation (GRADE) framework to assess evidence and the Delphi method to achieve \u226580% agreement.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Consensus was achieved on 28 statements. Eradication of\n                      <jats:italic>H pylori<\/jats:italic>\n                      , the primary cause of gastric cancer, reduces the risk of gastric cancer across all age groups, with the greatest risk reduction before the onset of premalignant conditions.\n                      <jats:italic>H pylori<\/jats:italic>\n                      eradication also promotes ulcer healing, prevents ulcer recurrence and reduces the risk of NSAID\/aspirin related ulcers.\n                      <jats:italic>H pylori<\/jats:italic>\n                      transmission primarily occurs within families, making family based approaches promising for reducing spread and improving treatment outcomes.\n                      <jats:italic>H pylori<\/jats:italic>\n                      screening should prioritise high risk populations.\n                      <jats:sup>13<\/jats:sup>\n                      C-urea breath test or monoclonal stool antigen tests are preferred. Validated serological testing is a feasible alternative in low prevalence settings when followed by confirmatory non-serological testing. Integrating\n                      <jats:italic>H pylori<\/jats:italic>\n                      screening into existing health programmes may optimise patient adherence and resource utilisation. Empiric eradication treatment, especially bismuth quadruple therapy, is recommended in regions with high\n                      <jats:italic>H pylori<\/jats:italic>\n                      antibiotic resistance for conventional antibiotics. Potassium competitive acid blocker based regimens are alternatives. Confirmatory testing is strongly recommended to ensure\n                      <jats:italic>H pylori<\/jats:italic>\n                      eradication. Endoscopy is suggested for\n                      <jats:italic>H pylori<\/jats:italic>\n                      infected individuals with a high risk of gastric cancer and\/or alarm features.\n                      <jats:italic>H pylori<\/jats:italic>\n                      eradication does not increase the risk of reflux oesophageal adenocarcinoma. Long term disruptions to the microbiota and resistome, as well as the environmental impact of increased antibiotic use, warrant further investigation. The development of an\n                      <jats:italic>H pylori<\/jats:italic>\n                      vaccine remains an unmet need, as does the establishment of a risk stratified approach informed by advanced genetic research.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>\n                      <jats:italic>H pylori<\/jats:italic>\n                      eradication is an effective prevention strategy for gastric cancer that should be offered to all infected adult individuals. Future research should prioritise determining the optimal timing for screening, evaluating long term individual and population outcomes, as well as identifying more precise risk stratification parameters.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/gutjnl-2025-336027","type":"journal-article","created":{"date-parts":[[2025,9,5]],"date-time":"2025-09-05T17:32:36Z","timestamp":1757093556000},"page":"1767-1791","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":78,"title":["Screening and eradication of\n                    <i>Helicobacter pylori f<\/i>\n                    or gastric cancer prevention: Taipei Global Consensus II"],"prefix":"10.1136","volume":"74","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7945-5408","authenticated-orcid":false,"given":"Jyh-Ming","family":"Liou","sequence":"first","affiliation":[{"name":"Department of Medicine, National Taiwan University Cancer Center, Taipei, Taiwan"},{"name":"Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan"},{"name":"Department of Internal Medicine, College of Medicine, National Taiwan University, Taipei, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8439-9036","authenticated-orcid":false,"given":"Peter","family":"Malfertheiner","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Hepatology and Infectious Diseases, Otto-von-Guericke University Magdeburg, Magdeburg, Germany"},{"name":"Medical Clinic II, Medical Clinic II, Ludwig Maximilian University Hospital, Munchen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2475-3835","authenticated-orcid":false,"given":"Tzu-Chan","family":"Hong","sequence":"additional","affiliation":[{"name":"Department of Medicine, National Taiwan University Cancer Center, Taipei, Taiwan"},{"name":"Department of Internal Medicine, College of Medicine, National Taiwan University, Taipei, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0954-0647","authenticated-orcid":false,"given":"Hsiu-Chi","family":"Cheng","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan"},{"name":"Institute of Clinical Medicine and Molecular Medicine, College of Medicine, National Cheng Kung University, Tainan, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8578-2974","authenticated-orcid":false,"given":"Kentaro","family":"Sugano","sequence":"additional","affiliation":[{"name":"Department of Medicine, Jichi Medical University, Tochigi, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2049-9959","authenticated-orcid":false,"given":"Shailja","family":"Shah","sequence":"additional","affiliation":[{"name":"Gastroenterology, University of California, San Diego; Veterans Affairs San Diego Healthcare System, San Diego, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bor-Shyang","family":"Sheu","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3284-004X","authenticated-orcid":false,"given":"Mei-Jyh","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan"},{"name":"Department of Internal Medicine, College of Medicine, National Taiwan University, Taipei, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsung-Hsien","family":"Chiang","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan"},{"name":"Department of Internal Medicine, College of Medicine, National Taiwan University, Taipei, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-3477-2526","authenticated-orcid":false,"given":"Yi-Chu","family":"Chen","sequence":"additional","affiliation":[{"name":"Institute of Epidemiology and Preventive Medicine, College of Public Health, National Taiwan University, Taipei City, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1222-5819","authenticated-orcid":false,"given":"Yoshio","family":"Yamaoka","sequence":"additional","affiliation":[{"name":"Department of Environmental and Preventive Medicine, Oita University Faculty of Medicine, Yufu, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3354-9310","authenticated-orcid":false,"given":"Sunny H","family":"Wong","sequence":"additional","affiliation":[{"name":"Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2953-210X","authenticated-orcid":false,"given":"Chieh-Chang","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan"},{"name":"Department of Internal Medicine, College of Medicine, National Taiwan University, Taipei, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6486-7717","authenticated-orcid":false,"given":"Yeong Yeh","family":"Lee","sequence":"additional","affiliation":[{"name":"School of Medical Sciences, Universiti Sains Malaysia, Kota Bharu, Kelantan, Malaysia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0141-921X","authenticated-orcid":false,"given":"Duc Trong","family":"Quach","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, University of Medicine and Pharmacy at Ho Chi Minh City, Ho Chi Minh City, Vietnam"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deng-chyang","family":"Wu","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3905-4674","authenticated-orcid":false,"given":"Ping-I","family":"Hsu","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology, Department of Internal Medicine, An Nan Hospital, China Medical University, Tainan, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5053-1801","authenticated-orcid":false,"given":"Chun-Ying","family":"Wu","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, School of Medicine, National Yang-Ming University, Taipei, Taiwan"},{"name":"Division of Gastroenterology, Department of Internal Medicine, Taipei Veterans General Hospital, Taipei City, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeng-Yih","family":"Wu","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiing-Chyuan","family":"Luo","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology, Department of Internal Medicine, Taipei Veterans General Hospital, Taipei City, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0238-527X","authenticated-orcid":false,"given":"Wei-Lun","family":"Chang","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3127-6048","authenticated-orcid":false,"given":"Hong","family":"Lu","sequence":"additional","affiliation":[{"name":"GI Division, Shanghai Jiao-Tong University School of Medicine Renji Hospital Shanghai Institution of Digestive Disease, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidekazu","family":"Suzuki","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology, Department of Internal Medicine, Tokai University School of Medicine Graduate School of Medicine, Isehara, Kanagawa, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1281-5859","authenticated-orcid":false,"given":"Hwoon-Yong","family":"Jung","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, University of Ulsan College of Medicine, Songpa-gu, Korea (the Republic of)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Varocha","family":"Mahachai","sequence":"additional","affiliation":[{"name":"Center of Excellence in Digestive Diseases, Gastroenterology Unit, Department of Medicine and Thailand Science Research and Innovation Fundamental Fund 2025, Thammasat University, Bangkok, Thailand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ratha-korn","family":"Vilaichone","sequence":"additional","affiliation":[{"name":"Center of Excellence in Digestive Diseases, Gastroenterology Unit, Department of Medicine and Thailand Science Research and Innovation Fundamental Fund 2025, Thammasat University, Bangkok, Thailand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francis","family":"M\u00e9graud","sequence":"additional","affiliation":[{"name":"INSERM U1312 BRIC, University of Bordeaux, Bordeaux, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9368-6141","authenticated-orcid":false,"given":"Jaw-Town","family":"Lin","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan"},{"name":"Department of Internal Medicine, E-DA Hospital and I-Shou University, Kaohsiung, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7802-4606","authenticated-orcid":false,"given":"Khay-Guan","family":"Yeoh","sequence":"additional","affiliation":[{"name":"Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wai Keung","family":"Leung","sequence":"additional","affiliation":[{"name":"Medicine, University of Hong Kong, Hong Kong, People's Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0011-3924","authenticated-orcid":false,"given":"Emad M","family":"El-Omar","sequence":"additional","affiliation":[{"name":"Microbiome Research Centre, School of Clinical Medicine, Faculty of Medicine and Health, University of New South Wales Sydney, Sydney, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8160-1216","authenticated-orcid":false,"given":"Yi-Chia","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan"},{"name":"Department of Internal Medicine, College of Medicine, National Taiwan University, Taipei, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-Shiang","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan"},{"name":"Department of Internal Medicine, College of Medicine, National Taiwan University, Taipei, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2025,9,5]]},"reference":[{"key":"2025120300250902000_74.11.1767.1","doi-asserted-by":"publisher","DOI":"10.3322\/CAAC.21834"},{"key":"2025120300250902000_74.11.1767.2","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(12)70137-7"},{"key":"2025120300250902000_74.11.1767.3","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2020-322368"},{"key":"2025120300250902000_74.11.1767.4","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2024.14887"},{"key":"2025120300250902000_74.11.1767.5","doi-asserted-by":"crossref","first-page":"3250","DOI":"10.1038\/s41591-024-03153-w","article-title":"Gastric cancer prevention by community eradication of Helicobacter pylori: a cluster-randomized controlled trial","volume":"30","author":"Pan","year":"2024","journal-title":"Nat Med"},{"key":"2025120300250902000_74.11.1767.6","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.1016\/S0140-6736(16)31409-X","article-title":"Concomitant, bismuth quadruple, and 14-day triple therapy in the first-line treatment of Helicobacter pylori: a multicentre, open-label, randomised trial","volume":"388","author":"Liou","year":"2016","journal-title":"Lancet"},{"key":"2025120300250902000_74.11.1767.7","doi-asserted-by":"publisher","DOI":"10.14309\/ajg.0000000000002968"},{"key":"2025120300250902000_74.11.1767.8","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1053\/j.gastro.2021.04.012","article-title":"Comparative Effectiveness of Multiple Different First-Line Treatment Regimens for Helicobacter pylori Infection: A Network Meta-analysis","volume":"161","author":"Rokkas","year":"2021","journal-title":"Gastroenterology"},{"key":"2025120300250902000_74.11.1767.9","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2023-329826"},{"key":"2025120300250902000_74.11.1767.10","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2024.03.016"},{"key":"2025120300250902000_74.11.1767.11","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/S2468-1253(22)00384-3","article-title":"Second-line levofloxacin-based quadruple therapy versus bismuth-based quadruple therapy for Helicobacter pylori eradication and long-term changes to the gut microbiota and antibiotic resistome: a multicentre, open-label, randomised controlled trial","volume":"8","author":"Liou","year":"2023","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"2025120300250902000_74.11.1767.12","doi-asserted-by":"crossref","unstructured":"Dorji T , Wangmo S , Dargay S , et al . Population-level cancer screening and cancer care in Bhutan, 2020-2023: a review. Lancet Reg Health Southeast Asia 2024;24. doi:10.1016\/j.lansea.2024.100370","DOI":"10.1016\/j.lansea.2024.100370"},{"key":"2025120300250902000_74.11.1767.13","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.328.7454.1490"},{"key":"2025120300250902000_74.11.1767.14","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2023.12.022"},{"key":"2025120300250902000_74.11.1767.15","unstructured":"Park JY , ed. Population-based helicobacter pylori screen-and-treat strategies for gastric cancer prevention: guidance on implementation (IARC working group reports no.12). Lyon, France: International Agency for Research on Cancer, 2025. Available: https:\/\/publications.iarc.who.int\/648"},{"key":"2025120300250902000_74.11.1767.16","doi-asserted-by":"publisher","DOI":"10.1136\/gut.49.3.347"},{"key":"2025120300250902000_74.11.1767.17","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa001999"},{"key":"2025120300250902000_74.11.1767.18","doi-asserted-by":"crossref","first-page":"2773","DOI":"10.1002\/ijc.32610","article-title":"Helicobacter pylori infection, chronic atrophic gastritis and risk of stomach and esophagus cancer: Results from the prospective population-based ESTHER cohort study","volume":"146","author":"Holleczek","year":"2020","journal-title":"Int J Cancer"},{"key":"2025120300250902000_74.11.1767.19","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.28999"},{"key":"2025120300250902000_74.11.1767.20","doi-asserted-by":"crossref","first-page":"e180","DOI":"10.1016\/S2214-109X(19)30488-7","article-title":"Global burden of cancer attributable to infections in 2018: a worldwide incidence analysis","volume":"8","author":"de Martel","year":"2020","journal-title":"Lancet Glob Health"},{"key":"2025120300250902000_74.11.1767.21","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1093\/ije\/dyad007","article-title":"Helicobacter pylori multiplex serology and risk of non-cardia and cardia gastric cancer: a case-cohort study and meta-analysis","volume":"52","author":"Yao","year":"2023","journal-title":"Int J Epidemiol"},{"key":"2025120300250902000_74.11.1767.22","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2006.01109.x"},{"key":"2025120300250902000_74.11.1767.23","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(00)03571-6"},{"key":"2025120300250902000_74.11.1767.24","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/92.23.1881"},{"key":"2025120300250902000_74.11.1767.25","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(95)90398-4"},{"key":"2025120300250902000_74.11.1767.26","first-page":"281","article-title":"Changes in the gastric mucosa following eradication of Helicobacter pylori","volume":"6","author":"Genta","year":"1993","journal-title":"Mod Pathol"},{"key":"2025120300250902000_74.11.1767.27","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1055\/s-2001-15968","article-title":"Short-term changes in Helicobacter pylori gastritis and bulbitis during and after 2 weeks of treatment with omeprazole and amoxicillin in duodenal ulcer patients","volume":"39","author":"Plein","year":"2001","journal-title":"Z Gastroenterol"},{"key":"2025120300250902000_74.11.1767.28","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1053\/j.gastro.2020.11.017","article-title":"The Colombian Chemoprevention Trial: 20-Year Follow-Up of a Cohort of Patients With Gastric Precancerous Lesions","volume":"160","author":"Piazuelo","year":"2021","journal-title":"Gastroenterology"},{"key":"2025120300250902000_74.11.1767.29","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1053\/j.gastro.2022.03.039","article-title":"Effect of Helicobacter pylori Eradication on Gastric Cancer Prevention: Updated Report From a Randomized Controlled Trial With 26.5 Years of Follow-up","volume":"163","author":"Yan","year":"2022","journal-title":"Gastroenterology"},{"key":"2025120300250902000_74.11.1767.30","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2003.034629"},{"key":"2025120300250902000_74.11.1767.31","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.l5016","article-title":"Effects of Helicobacter pylori treatment and vitamin and garlic supplementation on gastric cancer incidence and mortality: follow-up of a randomized intervention trial","volume":"366","author":"Li","year":"2019","journal-title":"BMJ"},{"key":"2025120300250902000_74.11.1767.32","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1909666"},{"key":"2025120300250902000_74.11.1767.33","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(08)61159-9"},{"key":"2025120300250902000_74.11.1767.34","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1708423"},{"key":"2025120300250902000_74.11.1767.35","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2016.01.028"},{"key":"2025120300250902000_74.11.1767.36","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1053\/j.gastro.2024.12.033","article-title":"Eradication Therapy to Prevent Gastric Cancer in Helicobacter pylori-Positive Individuals: Systematic Review and Meta-Analysis of Randomized Controlled Trials and Observational Studies","volume":"169","author":"Ford","year":"2025","journal-title":"Gastroenterology"},{"key":"2025120300250902000_74.11.1767.37","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1053\/j.gastro.2025.01.239","article-title":"Risk of Gastric Adenocarcinoma After Eradication of Helicobacter pylori","volume":"169","author":"Wiklund","year":"2025","journal-title":"Gastroenterology"},{"key":"2025120300250902000_74.11.1767.38","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2019.10.019"},{"key":"2025120300250902000_74.11.1767.39","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1053\/j.gastro.2023.04.026","article-title":"Effect of Helicobacter pylori Eradication Therapy on the Incidence of Noncardia Gastric Adenocarcinoma in a Large Diverse Population in the United States","volume":"165","author":"Li","year":"2023","journal-title":"Gastroenterology"},{"key":"2025120300250902000_74.11.1767.40","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2018.03.028"},{"key":"2025120300250902000_74.11.1767.41","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/s41572-023-00431-8","article-title":"Helicobacter pylori infection","volume":"9","author":"Malfertheiner","year":"2023","journal-title":"Nat Rev Dis Primers"},{"key":"2025120300250902000_74.11.1767.42","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.314.7080.565"},{"key":"2025120300250902000_74.11.1767.43","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(90)91301-P"},{"key":"2025120300250902000_74.11.1767.44","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199302043280503"},{"key":"2025120300250902000_74.11.1767.45","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199501193320302"},{"key":"2025120300250902000_74.11.1767.46","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.305.6852.502"},{"key":"2025120300250902000_74.11.1767.47","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2012-302240"},{"key":"2025120300250902000_74.11.1767.48","article-title":"Eradication therapy for peptic ulcer disease in Helicobacter pylori-positive people","volume":"4","author":"Ford","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"2025120300250902000_74.11.1767.49","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(02)07273-2"},{"key":"2025120300250902000_74.11.1767.50","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2005.02444.x"},{"key":"2025120300250902000_74.11.1767.51","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1111\/j.1523-5378.2012.00942.x","article-title":"Eradication of Helicobacter pylori infection reduces the incidence of peptic ulcer disease in patients using nonsteroidal anti-inflammatory drugs: a meta-analysis","volume":"17","author":"Tang","year":"2012","journal-title":"Helicobacter"},{"key":"2025120300250902000_74.11.1767.52","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(22)01843-8"},{"key":"2025120300250902000_74.11.1767.53","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-07-6786"},{"key":"2025120300250902000_74.11.1767.54","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-08-3856"},{"key":"2025120300250902000_74.11.1767.55","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.canlet.2014.09.010","article-title":"Early or late antibiotic intervention prevents Helicobacter pylori-induced gastric cancer in a mouse model","volume":"355","author":"Zhang","year":"2014","journal-title":"Cancer Lett"},{"key":"2025120300250902000_74.11.1767.56","doi-asserted-by":"publisher","DOI":"10.1038\/labinvest.3700719"},{"key":"2025120300250902000_74.11.1767.57","doi-asserted-by":"publisher","DOI":"10.1001\/jama.291.2.187"},{"key":"2025120300250902000_74.11.1767.58","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2009.07.060"},{"key":"2025120300250902000_74.11.1767.59","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1053\/j.gastro.2025.03.036","article-title":"Preventive Effect of Helicobacter pylori Treatment on Gastric Cancer Incidence and Mortality: A Korean Population Study","volume":"169","author":"Jung","year":"2025","journal-title":"Gastroenterology"},{"key":"2025120300250902000_74.11.1767.60","first-page":"72","article-title":"Helicobacter pylori, transmission routes and recurrence of infection: state of the art","volume":"89","author":"Kayali","year":"2018","journal-title":"Acta Biomed"},{"key":"2025120300250902000_74.11.1767.61","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2008.61"},{"key":"2025120300250902000_74.11.1767.62","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.epirev.a018040"},{"key":"2025120300250902000_74.11.1767.63","doi-asserted-by":"publisher","DOI":"10.1001\/jama.282.23.2240"},{"key":"2025120300250902000_74.11.1767.64","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1016\/S0016-5085(97)80004-2","article-title":"How is Helicobacter pylori transmitted?","volume":"113","author":"Cave","year":"1997","journal-title":"Gastroenterology"},{"key":"2025120300250902000_74.11.1767.65","doi-asserted-by":"publisher","DOI":"10.3201\/eid1211.060086"},{"key":"2025120300250902000_74.11.1767.66","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1515\/REVEH.2009.24.1.1","article-title":"Helicobacter pylori in Water Sources: A Global Environmental Health Concern","volume":"24","author":"Dube","year":"2009","journal-title":"Rev Environ Health"},{"key":"2025120300250902000_74.11.1767.67","doi-asserted-by":"publisher","DOI":"10.1128\/AEM.00047-07"},{"key":"2025120300250902000_74.11.1767.68","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2023-329871"},{"key":"2025120300250902000_74.11.1767.69","first-page":"297","article-title":"Helicobacter pylori and food products: a public health problem","volume":"268","author":"Herrera","year":"2004","journal-title":"Methods Mol Biol"},{"key":"2025120300250902000_74.11.1767.70","first-page":"93","article-title":"Non-human reservoirs of Helicobacter pylori","volume":"9 Suppl 2","author":"Fox","year":"1995","journal-title":"Aliment Pharmacol Ther"},{"key":"2025120300250902000_74.11.1767.71","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2020-322200"},{"key":"2025120300250902000_74.11.1767.72","first-page":"543","article-title":"Impact of household hygiene and water source on the prevalence and transmission of Helicobacter pylori: a South Indian perspective","volume":"48","author":"Ahmed","year":"2007","journal-title":"Singapore Med J"},{"key":"2025120300250902000_74.11.1767.73","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2022-064207","article-title":"School-based Hygiene Intervention to Prevent HelicObacter Pylori infection among childrEn (SHIP HOPE): protocol for a cluster-randomised controlled trial","volume":"12","author":"Zhou","year":"2022","journal-title":"BMJ Open"},{"key":"2025120300250902000_74.11.1767.74","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2022-328965"},{"key":"2025120300250902000_74.11.1767.75","doi-asserted-by":"publisher","DOI":"10.1017\/S0950268806006005"},{"key":"2025120300250902000_74.11.1767.76","doi-asserted-by":"crossref","DOI":"10.1111\/hel.12793","article-title":"Whole family-based Helicobacter pylori eradication is a superior strategy to single-infected patient treatment approach: A systematic review and meta-analysis","volume":"26","author":"Zhao","year":"2021","journal-title":"Helicobacter"},{"key":"2025120300250902000_74.11.1767.77","doi-asserted-by":"crossref","DOI":"10.1111\/hel.13123","article-title":"An Economic Evaluation of Family-Based Versus Traditional Helicobacter pylori Screen-and-Treat Strategy: Based on Real-World Data and Microsimulation Model","volume":"29","author":"Ma","year":"2024","journal-title":"Helicobacter"},{"key":"2025120300250902000_74.11.1767.78","article-title":"Non-invasive diagnostic tests for Helicobacter pylori infection","volume":"3","author":"Best","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"key":"2025120300250902000_74.11.1767.79","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2016-312288"},{"key":"2025120300250902000_74.11.1767.80","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-med-042220-020814"},{"key":"2025120300250902000_74.11.1767.81","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2006.00668.x"},{"key":"2025120300250902000_74.11.1767.82","unstructured":"Tepes TB , Gerhard M , Leung WK , et al . Considerations for choice of population-based H. pylori detection methods. In: Park JY , ed. Population-based Helicobacter pylori screen-and-treat strategies for gastric cancer prevention: guidance on implementation (IARC working group reports No. 12). Lyon, France: International Agency for Research on Cancer, 2025. Available: https:\/\/publications.iarc.who.int\/648"},{"key":"2025120300250902000_74.11.1767.83","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.clinre.2014.02.001","article-title":"Accuracy of stool antigen test for the diagnosis of Helicobacter pylori infection in children: a meta-analysis","volume":"38","author":"Zhou","year":"2014","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"2025120300250902000_74.11.1767.84","doi-asserted-by":"crossref","first-page":"8188","DOI":"10.3748\/wjg.v19.i45.8188","article-title":"Stool antigen tests for the management of Helicobacter pylori infection","volume":"19","author":"Shimoyama","year":"2013","journal-title":"World J Gastroenterol"},{"key":"2025120300250902000_74.11.1767.85","first-page":"45","article-title":"Impact of patient adherence on the cost-effectiveness of noninvasive tests for the initial diagnosis of Helicobacter pylori infection in the United States","volume":"10","author":"Boklage","year":"2016","journal-title":"Patient Prefer Adherence"},{"key":"2025120300250902000_74.11.1767.86","unstructured":"Screening strategy for gastric cancer prevention. clinicaltrials.gov id: nct05387005 . Available: https:\/\/www.clinicaltrials.gov\/study\/NCT05387005?term=UREA%20C-13&rank=8"},{"key":"2025120300250902000_74.11.1767.87","unstructured":"Moayyedi P , Lee YC , Gerhard M , et al . Antibiotic stewardship for population-based helicobacter pylori screen-and-treat, including testing of cure and monitoring of antibiotic resistance. In: Park JY , ed. Population-based Helicobacter pylori screen-and-treat strategies for gastric cancer prevention: guidance on implementation (IARC Working Group Reports No. 12). Lyon, France: International Agency for Research on Cancer, 2025. Available: https:\/\/publications.iarc.who.int\/648"},{"key":"2025120300250902000_74.11.1767.88","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2022-327745"},{"key":"2025120300250902000_74.11.1767.89","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2208375"},{"key":"2025120300250902000_74.11.1767.90","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2017.11389"},{"key":"2025120300250902000_74.11.1767.91","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1108895"},{"key":"2025120300250902000_74.11.1767.92","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/S2468-1253(21)00473-8","article-title":"Once-only colonoscopy or two rounds of faecal immunochemical testing 2 years apart for colorectal cancer screening (SCREESCO): preliminary report of a randomised controlled trial","volume":"7","author":"Forsberg","year":"2022","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"2025120300250902000_74.11.1767.93","doi-asserted-by":"crossref","DOI":"10.1056\/EVIDe2300310","article-title":"The Registry-Based Randomized Trial - A Pragmatic Study Design","volume":"3","author":"Troxel","year":"2024","journal-title":"NEJM Evid"},{"key":"2025120300250902000_74.11.1767.94","unstructured":"Lansdorp-Vogelaar I , M\u00fclder DT , Dinis-Ribeiro M , et al . How to optimize cost-benefits of h. pylori screen-and-treat programs for gastric cancer prevention. In: Park JY , ed. Population-based Helicobacter pylori screen-and-treat strategies for gastric cancer prevention: guidance on implementation (IARC working group reports no.12). Lyon, France: International Agency for Research on Cancer, 2025. Available: https:\/\/publications.iarc.who.int\/648"},{"key":"2025120300250902000_74.11.1767.95","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1001\/jama.2024.26389","article-title":"Screening for Helicobacter pylori to Prevent Gastric Cancer-Reply","volume":"333","author":"Lee","year":"2025","journal-title":"JAMA"},{"key":"2025120300250902000_74.11.1767.96","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2021.09.039"},{"key":"2025120300250902000_74.11.1767.97","unstructured":"World Health Organization . Screening programmes: a short guide. Increase effectiveness, maximize benefits and minimize harm. Copenhagen: WHO Regional Office for Europe, 2020."},{"key":"2025120300250902000_74.11.1767.98","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2019.05.032"},{"key":"2025120300250902000_74.11.1767.99","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1053\/j.gastro.2020.07.049","article-title":"Population-Based Analysis of Differences in Gastric Cancer Incidence Among Races and Ethnicities in Individuals Age 50 Years and Older","volume":"159","author":"Shah","year":"2020","journal-title":"Gastroenterology"},{"key":"2025120300250902000_74.11.1767.100","unstructured":"Lee YC , Lansdorp-Vogelaar I , Leja M , et al . Process and outcome measures for improving the quality and equity of H. pylori screen-and-treat programmes for gastric cancer prevention. In: Park JY , ed. Population-based Helicobacter pylori screen-and-treat strategies for gastric cancer prevention: guidance on implementation (IARC working group reports no. 12). Lyon, France: International Agency for Research on Cancer, 2025. Available: https:\/\/publications.iarc.who.int\/648"},{"key":"2025120300250902000_74.11.1767.101","doi-asserted-by":"publisher","DOI":"10.1111\/jgh.14898"},{"key":"2025120300250902000_74.11.1767.102","doi-asserted-by":"publisher","DOI":"10.1093\/jjco\/hyy077"},{"key":"2025120300250902000_74.11.1767.103","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2021-325630"},{"key":"2025120300250902000_74.11.1767.104","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/j.gastrohep.2024.01.008","article-title":"Chilean consensus by expert panel using the Delphi technique for primary and secondary prevention of gastric cancer","volume":"47","author":"Corsi Sotelo","year":"2024","journal-title":"Gastroenterol Hepatol"},{"key":"2025120300250902000_74.11.1767.105","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/S0140-6736(22)00153-2","article-title":"Accelerating Indigenous health and wellbeing: the Lancet Commission on Arctic and Northern Health","volume":"399","author":"Adams","year":"2022","journal-title":"Lancet"},{"key":"2025120300250902000_74.11.1767.106","doi-asserted-by":"crossref","DOI":"10.1186\/s12879-017-2259-2","article-title":"A screening program to test and treat for Helicobacter pylori infection: Cost-utility analysis by age, sex and ethnicity","volume":"17","author":"Teng","year":"2017","journal-title":"BMC Infect Dis"},{"key":"2025120300250902000_74.11.1767.107","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2024-332705"},{"key":"2025120300250902000_74.11.1767.108","doi-asserted-by":"crossref","first-page":"169","DOI":"10.5230\/jgc.2022.22.e22","article-title":"Current Evidence for a Paradigm Shift in Gastric Cancer Prevention From Endoscopic Screening to Helicobacter pylori Eradication in Korea","volume":"22","author":"Kim","year":"2022","journal-title":"J Gastric Cancer"},{"key":"2025120300250902000_74.11.1767.109","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2017.01.029"},{"key":"2025120300250902000_74.11.1767.110","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1053\/j.gastro.2024.11.025","article-title":"Effect of an Endoscopy Screening on Upper Gastrointestinal Cancer Mortality: A Community-Based Multicenter Cluster Randomized Clinical Trial","volume":"168","author":"Xia","year":"2025","journal-title":"Gastroenterology"},{"key":"2025120300250902000_74.11.1767.111","unstructured":"Ferlay J , Ervik M , Lam F , et al . Global cancer observatory: cancer today. Lyon, France:International Agency for Research on Cancer; 2024. Available: https:\/\/gco.iarc.who.int\/today"},{"key":"2025120300250902000_74.11.1767.112","unstructured":"Leung WK , Camargo MC , Goodman KJ , et al . Needs and readiness for the implementation of H. pylori screen-and-treat strategies for gastric cancer prevention locally. In: Park JY , ed. Population-based Helicobacter pylori screen-and-treat strategies for gastric cancer prevention: guidance on implementation (IARC working group reports no. 12). Lyon, France: International Agency for Research on Cancer, Available: https:\/\/publications.iarc.who.int\/648"},{"key":"2025120300250902000_74.11.1767.113","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1001\/jama.2024.8611","article-title":"Fecal Immunochemical Test and Helicobacter pylori Stool Antigen Co-Testing: A Potential Approach for Gastric Cancer Screening","volume":"332","author":"Camargo","year":"2024","journal-title":"JAMA"},{"key":"2025120300250902000_74.11.1767.114","doi-asserted-by":"publisher","DOI":"10.1016\/j.bpg.2013.09.005"},{"key":"2025120300250902000_74.11.1767.115","doi-asserted-by":"crossref","first-page":"2378","DOI":"10.1016\/j.jfma.2022.08.012","article-title":"Mass screening and eradication of Helicobacter pylori as the policy recommendations for gastric cancer prevention","volume":"121","author":"Chiang","year":"2022","journal-title":"J Formos Med Assoc"},{"key":"2025120300250902000_74.11.1767.116","doi-asserted-by":"crossref","DOI":"10.1111\/hel.13120","article-title":"Cost-Effectiveness of Population-Based Helicobacter pylori Screening With Eradication for Optimal Age of Implementation","volume":"29","author":"Kowada","year":"2024","journal-title":"Helicobacter"},{"key":"2025120300250902000_74.11.1767.117","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1053\/j.gastro.2021.08.042","article-title":"Testing and Treating Helicobacter pylori Infection in Individuals With Family History of Gastric Cancer is Cost-effective","volume":"161","author":"Rustgi","year":"2021","journal-title":"Gastroenterology"},{"key":"2025120300250902000_74.11.1767.118","doi-asserted-by":"crossref","DOI":"10.1111\/hel.12563","article-title":"Cost-effectiveness analysis of screen-and-treat strategy in asymptomatic Chinese for preventing Helicobacter pylori-associated diseases","volume":"24","author":"Chen","year":"2019","journal-title":"Helicobacter"},{"key":"2025120300250902000_74.11.1767.119","doi-asserted-by":"crossref","first-page":"101735","DOI":"10.1016\/j.bpg.2021.101735","article-title":"Cost-effectiveness of prevention and early detection of gastric cancer in Western countries","volume":"50\u201351","author":"Lansdorp-Vogelaar","year":"2021","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"2025120300250902000_74.11.1767.120","unstructured":"Colon cancer screening. U.S. Preventive Services Task Force. 2021 Available: https:\/\/www.uspreventiveservicestaskforce.org\/uspstf\/recommendation\/colorectal-cancer-screening"},{"key":"2025120300250902000_74.11.1767.121","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1053\/j.gastro.2016.12.010","article-title":"Germline Mutations in PALB2, BRCA1, and RAD51C, Which Regulate DNA Recombination Repair, in Patients With Gastric Cancer","volume":"152","author":"Sahasrabudhe","year":"2017","journal-title":"Gastroenterology"},{"key":"2025120300250902000_74.11.1767.122","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2211807"},{"key":"2025120300250902000_74.11.1767.123","doi-asserted-by":"publisher","DOI":"10.1038\/s41588-023-01333-x"},{"key":"2025120300250902000_74.11.1767.124","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1007\/s10120-024-01494-6","article-title":"Global burden of young-onset gastric cancer: a systematic trend analysis of the global burden of disease study 2019","volume":"27","author":"Li","year":"2024","journal-title":"Gastric Cancer"},{"key":"2025120300250902000_74.11.1767.125","doi-asserted-by":"crossref","DOI":"10.14309\/ctg.0000000000000430","article-title":"Polygenic Risk Scores for Prediction of Gastric Cancer Based on Bioinformatics Screening and Validation of Functional lncRNA SNPs","volume":"12","author":"Duan","year":"2021","journal-title":"Clin Transl Gastroenterol"},{"key":"2025120300250902000_74.11.1767.126","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2019-318760"},{"key":"2025120300250902000_74.11.1767.127","doi-asserted-by":"crossref","DOI":"10.1186\/s12885-019-5355-4","article-title":"Blood groups A and AB are associated with increased gastric cancer risk: evidence from a large genetic study and systematic review","volume":"19","author":"Mao","year":"2019","journal-title":"BMC Cancer"},{"key":"2025120300250902000_74.11.1767.128","doi-asserted-by":"publisher","DOI":"10.1007\/s11033-013-2682-4"},{"key":"2025120300250902000_74.11.1767.129","doi-asserted-by":"crossref","DOI":"10.1111\/hel.13015","article-title":"Efficacy of genotypic susceptibility-guided tailored therapy for Helicobacter pylori infection: A systematic review and single arm meta-analysis","volume":"28","author":"Lin","year":"2023","journal-title":"Helicobacter"},{"key":"2025120300250902000_74.11.1767.130","doi-asserted-by":"crossref","DOI":"10.1111\/hel.12936","article-title":"Current role of tailored therapy in treating Helicobacter pylori infections. A systematic review, meta-analysis and critical analysis","volume":"28","author":"Rokkas","year":"2023","journal-title":"Helicobacter"},{"key":"2025120300250902000_74.11.1767.131","doi-asserted-by":"crossref","first-page":"2649","DOI":"10.1111\/jgh.15575","article-title":"Susceptibility-guided versus empirical treatment for Helicobacter pylori infection: A systematic review and meta-analysis","volume":"36","author":"Gingold-Belfer","year":"2021","journal-title":"J Gastroenterol Hepatol"},{"key":"2025120300250902000_74.11.1767.132","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2018.06.047"},{"key":"2025120300250902000_74.11.1767.133","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/S2468-1253(23)00097-3","article-title":"Molecular testing-guided therapy versus susceptibility testing-guided therapy in first-line and third-line Helicobacter pylori eradication: two multicentre, open-label, randomised controlled, non-inferiority trials","volume":"8","author":"Chen","year":"2023","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"2025120300250902000_74.11.1767.134","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1136\/gutjnl-2024-332804","article-title":"Evolution of the use, effectiveness and safety of bismuth-containing quadruple therapy for Helicobacter pylori infection between 2013 and 2021: results from the European registry on H. pylori management (Hp-EuReg)","volume":"74","author":"Olmedo","year":"2024","journal-title":"Gut"},{"key":"2025120300250902000_74.11.1767.135","unstructured":"World Health Organization . Antimicrobial stewardship programmes in health-care facilities in low- and middle-income countries: a WHO practical toolkit. Geneva: WHO, 2019. Available: https:\/\/www.who.int\/publications-detail\/9789241515481"},{"key":"2025120300250902000_74.11.1767.136","doi-asserted-by":"crossref","DOI":"10.1111\/hel.12368","article-title":"Consensus on the clinical management, screening-to-treat, and surveillance of Helicobacter pylori infection to improve gastric cancer control on a nationwide scale","volume":"22","author":"Sheu","year":"2017","journal-title":"Helicobacter"},{"key":"2025120300250902000_74.11.1767.137","doi-asserted-by":"crossref","DOI":"10.1111\/hel.12570","article-title":"Meta-analysis of three-in-one single capsule bismuth-containing quadruple therapy for the eradication of Helicobacter pylori","volume":"24","author":"Nyssen","year":"2019","journal-title":"Helicobacter"},{"key":"2025120300250902000_74.11.1767.138","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/S2468-1253(17)30219-4","article-title":"Primary antibiotic resistance in Helicobacter pylori in the Asia-Pacific region: a systematic review and meta-analysis","volume":"2","author":"Kuo","year":"2017","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"2025120300250902000_74.11.1767.139","doi-asserted-by":"crossref","DOI":"10.3390\/microorganisms13040715","article-title":"Dual Therapies Containing an Antibiotic Plus a Proton Pump Inhibitor or Vonoprazan for Helicobacter pylori Infection: A Systematic Review","volume":"13","author":"Shih","year":"2025","journal-title":"Microorganisms"},{"key":"2025120300250902000_74.11.1767.140","doi-asserted-by":"publisher","DOI":"10.1038\/nrgastro.2016.195"},{"key":"2025120300250902000_74.11.1767.141","doi-asserted-by":"crossref","DOI":"10.1186\/s12929-018-0471-z","article-title":"Toward population specific and personalized treatment of Helicobacter pylori infection","volume":"25","author":"Liou","year":"2018","journal-title":"J Biomed Sci"},{"key":"2025120300250902000_74.11.1767.142","doi-asserted-by":"crossref","unstructured":"Kotilea K , Mekhael J , Salame A , et al . Eradication rate of Helicobacter Pylori infection is directly influenced by adherence to therapy in children. Helicobacter 2017;22. doi:10.1111\/hel.12383","DOI":"10.1111\/hel.12383"},{"key":"2025120300250902000_74.11.1767.143","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2007.07.008"},{"key":"2025120300250902000_74.11.1767.144","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2016-311868"},{"key":"2025120300250902000_74.11.1767.145","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.f4587","article-title":"Global eradication rates for Helicobacter pylori infection: systematic review and meta-analysis of sequential therapy","volume":"347","author":"Gatta","year":"2013","journal-title":"BMJ"},{"key":"2025120300250902000_74.11.1767.146","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(19)30272-5"},{"key":"2025120300250902000_74.11.1767.147","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00140-17","article-title":"A Randomized Controlled Trial Shows that both 14-Day Hybrid and Bismuth Quadruple Therapies Cure Most Patients with Helicobacter pylori Infection in Populations with Moderate Antibiotic Resistance","volume":"61","author":"Tsay","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"2025120300250902000_74.11.1767.148","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dky183"},{"key":"2025120300250902000_74.11.1767.149","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.14309\/ajg.0000000000002255","article-title":"Hybrid, High-Dose Dual and Bismuth Quadruple Therapies for First-Line Treatment of Helicobacter pylori Infection in Taiwan: A Multicenter, Open-Label, Randomized Trial","volume":"118","author":"Hsu","year":"2023","journal-title":"Am J Gastroenterol"},{"key":"2025120300250902000_74.11.1767.150","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2022.05.055"},{"key":"2025120300250902000_74.11.1767.151","doi-asserted-by":"crossref","DOI":"10.1111\/hel.13133","article-title":"Vonoprazan Dual or Triple Therapy Versus Bismuth-Quadruple Therapy as First-Line Therapy for Helicobacter pylori Infection: A Three-Arm, Randomized Clinical Trial","volume":"29","author":"Cheung","year":"2024","journal-title":"Helicobacter"},{"key":"2025120300250902000_74.11.1767.152","doi-asserted-by":"crossref","DOI":"10.1111\/hel.13098","article-title":"Fourteen-Day Tegoprazan-Amoxicillin Dual Therapy as the First-Line Treatment of Helicobacter pylori Infection (SHARE2301): A Multicenter, Noninferiority, Randomized Clinical Trial","volume":"29","author":"Kong","year":"2024","journal-title":"Helicobacter"},{"key":"2025120300250902000_74.11.1767.153","doi-asserted-by":"crossref","DOI":"10.1111\/hel.13129","article-title":"Seven-Day Vonoprazan-Based Triple Therapy as First-Line Helicobacter pylori Treatment in Comparison With Extended Sequential Therapy: A Randomized Controlled Trial","volume":"29","author":"Chiu","year":"2024","journal-title":"Helicobacter"},{"key":"2025120300250902000_74.11.1767.154","doi-asserted-by":"crossref","first-page":"655","DOI":"10.14309\/ajg.0000000000002592","article-title":"Ten-Day Vonoprazan-Amoxicillin Dual Therapy vs Standard 14-Day Bismuth-Based Quadruple Therapy for First-Line Helicobacter pylori Eradication: A Multicenter Randomized Clinical Trial","volume":"119","author":"Yan","year":"2024","journal-title":"Am J Gastroenterol"},{"key":"2025120300250902000_74.11.1767.155","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2009.198309"},{"key":"2025120300250902000_74.11.1767.156","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1016\/j.cgh.2018.03.031","article-title":"Equivalent Efficacies of Reverse Hybrid and Bismuth Quadruple Therapies in Eradication of Helicobacter pylori Infection in a Randomized Controlled Trial","volume":"16","author":"Hsu","year":"2018","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2025120300250902000_74.11.1767.157","doi-asserted-by":"crossref","DOI":"10.1111\/hel.12699","article-title":"Susceptibility-guided therapy for Helicobacter pylori-infected penicillin-allergic patients: A prospective clinical trial of first-line and rescue therapies","volume":"25","author":"Luo","year":"2020","journal-title":"Helicobacter"},{"key":"2025120300250902000_74.11.1767.158","doi-asserted-by":"crossref","unstructured":"Ono S , Kato M , Nakagawa S , et al . Vonoprazan improves the efficacy of Helicobacter pylori eradication therapy with a regimen consisting of clarithromycin and metronidazole in patients allergic to penicillin. Helicobacter 2017;22. doi:10.1111\/hel.12374","DOI":"10.1111\/hel.12374"},{"key":"2025120300250902000_74.11.1767.159","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/2019802","article-title":"First-Line Helicobacter pylori Eradication with Vonoprazan, Clarithromycin, and Metronidazole in Patients Allergic to Penicillin","volume":"2017","author":"Sue","year":"2017","journal-title":"Gastroenterol Res Pract"},{"key":"2025120300250902000_74.11.1767.160","doi-asserted-by":"crossref","DOI":"10.1177\/17562848241299734","article-title":"The efficacy and safety of a simple 14-day vonoprazan-minocycline dual therapy for Helicobacter pylori eradication: a retrospective pilot study","volume":"17","author":"Wang","year":"2024","journal-title":"Therap Adv Gastroenterol"},{"key":"2025120300250902000_74.11.1767.161","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2024-332640"},{"key":"2025120300250902000_74.11.1767.162","doi-asserted-by":"crossref","DOI":"10.3390\/jcm13133774","article-title":"Single-Arm, Prospective, Interventional Study of Helicobacter pylori Eradication Rescue Therapy with Rifabutin, Metronidazole, and Vonoprazan","volume":"13","author":"Sue","year":"2024","journal-title":"J Clin Med"},{"key":"2025120300250902000_74.11.1767.163","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2006.02737.x"},{"key":"2025120300250902000_74.11.1767.164","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/S2468-1253(23)00281-9","article-title":"Primary antibiotic resistance of Helicobacter pylori in the Asia-Pacific region between 1990 and 2022: an updated systematic review and meta-analysis","volume":"9","author":"Hong","year":"2024","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"2025120300250902000_74.11.1767.165","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1111\/apt.13712","article-title":"Systematic review with meta-analysis: the efficacy of levofloxacin triple therapy as the first- or second-line treatments of Helicobacter pylori infection","volume":"44","author":"Chen","year":"2016","journal-title":"Aliment Pharmacol Ther"},{"key":"2025120300250902000_74.11.1767.166","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2015.439"},{"key":"2025120300250902000_74.11.1767.167","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2021.03.026"},{"key":"2025120300250902000_74.11.1767.168","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2015-309252"},{"key":"2025120300250902000_74.11.1767.169","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.160.9.1285"},{"key":"2025120300250902000_74.11.1767.170","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9343(99)00196-5"},{"key":"2025120300250902000_74.11.1767.171","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.3748\/wjg.v23.i13.2435","article-title":"What is the quantitative risk of gastric cancer in the first-degree relatives of patients? A meta-analysis","volume":"23","author":"Yaghoobi","year":"2017","journal-title":"World J Gastroenterol"},{"key":"2025120300250902000_74.11.1767.172","doi-asserted-by":"publisher","DOI":"10.1097\/MCG.0000000000000992"},{"key":"2025120300250902000_74.11.1767.173","doi-asserted-by":"publisher","DOI":"10.1111\/jgh.15187"},{"key":"2025120300250902000_74.11.1767.174","doi-asserted-by":"crossref","DOI":"10.1186\/s12876-022-02155-7","article-title":"Brand interchangeability of pepsinogen tests in the real-world setting after eradication of Helicobacter pylori: a community-based study","volume":"22","author":"Chiang","year":"2022","journal-title":"BMC Gastroenterol"},{"key":"2025120300250902000_74.11.1767.175","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5107(05)00366-4"},{"key":"2025120300250902000_74.11.1767.176","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0219865","article-title":"Gastric cancer in patients with gastric atrophy and intestinal metaplasia: A systematic review and meta-analysis","volume":"14","author":"Akbari","year":"2019","journal-title":"PLoS One"},{"key":"2025120300250902000_74.11.1767.177","doi-asserted-by":"publisher","DOI":"10.1007\/s10120-018-0812-3"},{"key":"2025120300250902000_74.11.1767.178","doi-asserted-by":"publisher","DOI":"10.1038\/s41395-018-0353-8"},{"key":"2025120300250902000_74.11.1767.179","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2021-324057"},{"key":"2025120300250902000_74.11.1767.180","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.jfma.2022.11.008","article-title":"Evolution of the Correa\u2019s cascade steps: A long-term endoscopic surveillance among non-ulcer dyspepsia and gastric ulcer after H. pylori eradication","volume":"122","author":"Cheng","year":"2023","journal-title":"J Formos Med Assoc"},{"key":"2025120300250902000_74.11.1767.181","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/jgh.15177","article-title":"Endoscopic grading of gastric atrophy on risk assessment of gastric neoplasia: A systematic review and meta-analysis","volume":"36","author":"Xiao","year":"2021","journal-title":"J Gastroenterol Hepatol"},{"key":"2025120300250902000_74.11.1767.182","doi-asserted-by":"crossref","DOI":"10.3390\/jcm8050657","article-title":"Prediction of Chronic Atrophic Gastritis and Gastric Neoplasms by Serum Pepsinogen Assay: A Systematic Review and Meta-Analysis of Diagnostic Test Accuracy","volume":"8","author":"Bang","year":"2019","journal-title":"J Clin Med"},{"key":"2025120300250902000_74.11.1767.183","doi-asserted-by":"publisher","DOI":"10.1111\/hel.12150"},{"key":"2025120300250902000_74.11.1767.184","doi-asserted-by":"publisher","DOI":"10.1111\/j.1523-5378.2010.00752.x"},{"key":"2025120300250902000_74.11.1767.185","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/j.bpg.2016.09.001","article-title":"Cost effectiveness of surveillance for GI cancers","volume":"30","author":"Omidvari","year":"2016","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"2025120300250902000_74.11.1767.186","doi-asserted-by":"publisher","DOI":"10.1136\/gut.52.3.453"},{"key":"2025120300250902000_74.11.1767.187","doi-asserted-by":"publisher","DOI":"10.1001\/archsurg.140.7.644"},{"key":"2025120300250902000_74.11.1767.188","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2016.188"},{"key":"2025120300250902000_74.11.1767.189","doi-asserted-by":"publisher","DOI":"10.1007\/s10120-006-0408-1"},{"key":"2025120300250902000_74.11.1767.190","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1007\/s10120-015-0544-6","article-title":"Incidence of and risk factors for metachronous gastric cancer after endoscopic resection and successful Helicobacter pylori eradication: results of a large-scale, multicenter cohort study in Japan","volume":"19","author":"Mori","year":"2016","journal-title":"Gastric Cancer"},{"key":"2025120300250902000_74.11.1767.191","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1016\/j.gie.2015.10.024","article-title":"Incidence of gastric cancer after endoscopic resection of gastric adenoma","volume":"83","author":"Yoon","year":"2016","journal-title":"Gastrointest Endosc"},{"key":"2025120300250902000_74.11.1767.192","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.25030"},{"key":"2025120300250902000_74.11.1767.193","doi-asserted-by":"crossref","first-page":"2424","DOI":"10.3748\/wjg.v22.i8.2424","article-title":"Current status in remnant gastric cancer after distal gastrectomy","volume":"22","author":"Ohira","year":"2016","journal-title":"World J Gastroenterol"},{"key":"2025120300250902000_74.11.1767.194","doi-asserted-by":"publisher","DOI":"10.1007\/s10120-020-01042-y"},{"key":"2025120300250902000_74.11.1767.195","doi-asserted-by":"publisher","DOI":"10.1097\/MEG.0b013e3283398d37"},{"key":"2025120300250902000_74.11.1767.196","doi-asserted-by":"crossref","DOI":"10.1111\/hel.12578","article-title":"Spasmolytic polypeptide-expressing metaplasia associated with higher expressions of miR-21, 155, and 223 can be regressed by Helicobacter pylori eradication in the gastric cancer familial relatives","volume":"24","author":"Kuo","year":"2019","journal-title":"Helicobacter"},{"key":"2025120300250902000_74.11.1767.197","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1111\/ajco.13704","article-title":"Screening and surveillance for gastric cancer: Does family history play an important role in shaping our strategy?","volume":"18","author":"Luu","year":"2022","journal-title":"Asia Pac J Clin Oncol"},{"key":"2025120300250902000_74.11.1767.198","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2015-0205"},{"key":"2025120300250902000_74.11.1767.199","doi-asserted-by":"crossref","first-page":"i13","DOI":"10.1136\/gut.2004.041533","article-title":"The interplay between Helicobacter pylori, gastro-oesophageal reflux disease, and intestinal metaplasia","volume":"54 Suppl 1","author":"Malfertheiner","year":"2005","journal-title":"Gut"},{"key":"2025120300250902000_74.11.1767.200","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.2003.01695.x"},{"key":"2025120300250902000_74.11.1767.201","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.38082.626725.EE"},{"key":"2025120300250902000_74.11.1767.202","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2009.734"},{"key":"2025120300250902000_74.11.1767.203","doi-asserted-by":"publisher","DOI":"10.1177\/2050640613484020"},{"key":"2025120300250902000_74.11.1767.204","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.2002.01189.x"},{"key":"2025120300250902000_74.11.1767.205","doi-asserted-by":"publisher","DOI":"10.1136\/gut.53.1.12"},{"key":"2025120300250902000_74.11.1767.206","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2003.012641"},{"key":"2025120300250902000_74.11.1767.207","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199604183341603"},{"key":"2025120300250902000_74.11.1767.208","doi-asserted-by":"crossref","DOI":"10.1111\/hel.12688","article-title":"Helicobacter pylori eradication treatment and the risk of Barrett\u2019s esophagus and esophageal adenocarcinoma","volume":"25","author":"Doorakkers","year":"2020","journal-title":"Helicobacter"},{"key":"2025120300250902000_74.11.1767.209","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1016\/j.cgh.2018.03.030","article-title":"Low Incidence of Esophageal Adenocarcinoma After Eradication of Helicobacter pylori in Japan","volume":"16","author":"Take","year":"2018","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2025120300250902000_74.11.1767.210","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2022-328075"},{"key":"2025120300250902000_74.11.1767.211","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.23.00703"},{"key":"2025120300250902000_74.11.1767.212","doi-asserted-by":"crossref","DOI":"10.1177\/17562848231170943","article-title":"Long-term effect of Helicobacter pylori eradication on colorectal cancer incidences","volume":"16","author":"Guo","year":"2023","journal-title":"Therap Adv Gastroenterol"},{"key":"2025120300250902000_74.11.1767.213","doi-asserted-by":"crossref","DOI":"10.1111\/hel.70001","article-title":"Helicobacter pylori Eradication Therapy and the Risk of Colorectal Cancer: A Population-Based Nationwide Cohort Study in Sweden","volume":"29","author":"Liu","year":"2024","journal-title":"Helicobacter"},{"key":"2025120300250902000_74.11.1767.214","doi-asserted-by":"crossref","DOI":"10.3390\/jcm11237050","article-title":"The Effect of Quadruple Therapy with Polaprezinc or Bismuth on Gut Microbiota after Helicobacter pylori Eradication: A Randomized Controlled Trial","volume":"11","author":"Wu","year":"2022","journal-title":"J Clin Med"},{"key":"2025120300250902000_74.11.1767.215","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0151893","article-title":"Helicobacter pylori Eradication Causes Perturbation of the Human Gut Microbiome in Young Adults","volume":"11","author":"Yap","year":"2016","journal-title":"PLoS One"},{"key":"2025120300250902000_74.11.1767.216","doi-asserted-by":"crossref","DOI":"10.1111\/hel.12721","article-title":"Long-term changes in the gut microbiota after 14-day bismuth quadruple therapy in penicillin-allergic children","volume":"25","author":"Zhou","year":"2020","journal-title":"Helicobacter"},{"key":"2025120300250902000_74.11.1767.217","doi-asserted-by":"crossref","DOI":"10.1111\/hel.12809","article-title":"Long-term changes in the gut microbiota after triple therapy, sequential therapy, bismuth quadruple therapy and concomitant therapy for Helicobacter pylori eradication in Chinese children","volume":"26","author":"Zhou","year":"2021","journal-title":"Helicobacter"},{"key":"2025120300250902000_74.11.1767.218","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-80802-3","article-title":"Gut microbiota changes related to Helicobacter pylori eradication with vonoprazan containing triple therapy among adolescents: a prospective multicenter study","volume":"11","author":"Kakiuchi","year":"2021","journal-title":"Sci Rep"},{"key":"2025120300250902000_74.11.1767.219","doi-asserted-by":"crossref","first-page":"417","DOI":"10.3389\/fmed.2020.00417","article-title":"H. pylori Eradication Treatment Causes Alterations in the Gut Microbiota and Blood Lipid Levels","volume":"7","author":"Mart\u00edn-N\u00fa\u00f1ez","year":"2020","journal-title":"Front Med"},{"key":"2025120300250902000_74.11.1767.220","doi-asserted-by":"crossref","DOI":"10.1186\/s12866-022-02732-6","article-title":"The impact of Helicobacter pylori infection and eradication therapy containing minocycline and metronidazole on intestinal microbiota","volume":"22","author":"Cui","year":"2022","journal-title":"BMC Microbiol"},{"key":"2025120300250902000_74.11.1767.221","doi-asserted-by":"publisher","DOI":"10.1126\/science.aaf9286"},{"key":"2025120300250902000_74.11.1767.222","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-139-6-200309160-00011"},{"key":"2025120300250902000_74.11.1767.223","doi-asserted-by":"publisher","DOI":"10.1080\/00365540701299608"},{"key":"2025120300250902000_74.11.1767.224","doi-asserted-by":"publisher","DOI":"10.1111\/jgh.14736"},{"key":"2025120300250902000_74.11.1767.225","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(15)00473-0"},{"key":"2025120300250902000_74.11.1767.226","doi-asserted-by":"publisher","DOI":"10.1016\/j.mam.2023.101183"},{"key":"2025120300250902000_74.11.1767.227","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/S2468-1253(18)30125-0","article-title":"Efficacy, immunogenicity, and safety of a parenteral vaccine against Helicobacter pylori in healthy volunteers challenged with a Cag-positive strain: a randomised, placebo-controlled phase 1\/2 study","volume":"3","author":"Malfertheiner","year":"2018","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"2025120300250902000_74.11.1767.228","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2017.10.014"},{"key":"2025120300250902000_74.11.1767.229","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2008.05.054"},{"key":"2025120300250902000_74.11.1767.230","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/S0264-410X(01)00391-7","article-title":"Safety and immunogenicity of live recombinant Salmonella enterica serovar Typhi Ty21a expressing urease A and B from Helicobacter pylori in human volunteers","volume":"20","author":"Bumann","year":"2001","journal-title":"Vaccine (Auckl)"},{"key":"2025120300250902000_74.11.1767.231","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.69.6.3581-3590.2001"},{"key":"2025120300250902000_74.11.1767.232","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jit625"},{"key":"2025120300250902000_74.11.1767.233","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1016\/j.vaccine.2003.11.020","article-title":"Impact of vector-priming on the immunogenicity of a live recombinant Salmonella enterica serovar typhi Ty21a vaccine expressing urease A and B from Helicobacter pylori in human volunteers","volume":"22","author":"Metzger","year":"2004","journal-title":"Vaccine (Auckl)"},{"key":"2025120300250902000_74.11.1767.234","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1016\/j.vaccine.2010.12.130","article-title":"HelicoVax: epitope-based therapeutic Helicobacter pylori vaccination in a mouse model","volume":"29","author":"Moss","year":"2011","journal-title":"Vaccine (Auckl)"},{"key":"2025120300250902000_74.11.1767.235","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.2000.00825.x"},{"key":"2025120300250902000_74.11.1767.236","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(15)60310-5"},{"key":"2025120300250902000_74.11.1767.237","doi-asserted-by":"crossref","unstructured":"Bugaytsova JA , Piddubnyi A , Tkachenko I , et al . Vaccination with helicobacter pylori attachment proteins protects against gastric cancer immunology. bioRxiv 2023.05.25.542131 [Preprint] 2023. doi:10.1101\/2023.05.25.542131","DOI":"10.1101\/2023.05.25.542131"},{"key":"2025120300250902000_74.11.1767.238","doi-asserted-by":"publisher","DOI":"10.1172\/JCI45041"},{"key":"2025120300250902000_74.11.1767.239","doi-asserted-by":"publisher","DOI":"10.1111\/cea.12996"},{"key":"2025120300250902000_74.11.1767.240","doi-asserted-by":"publisher","DOI":"10.1097\/MIB.0000000000000318"},{"key":"2025120300250902000_74.11.1767.241","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1211248110"},{"key":"2025120300250902000_74.11.1767.242","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2015-310545"},{"key":"2025120300250902000_74.11.1767.243","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/apt.15306","article-title":"Systematic review with meta-analysis: association between Helicobacter pylori CagA seropositivity and odds of inflammatory bowel disease","volume":"50","author":"Tepler","year":"2019","journal-title":"Aliment Pharmacol Ther"},{"key":"2025120300250902000_74.11.1767.244","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2018.12.014"},{"key":"2025120300250902000_74.11.1767.245","doi-asserted-by":"crossref","first-page":"692","DOI":"10.3748\/wjg.v29.i4.692","article-title":"Disease trends after Helicobacter pylori eradication based on Japanese nationwide claims and the health check-up database","volume":"29","author":"Mizukami","year":"2023","journal-title":"World J Gastroenterol"}],"container-title":["Gut"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/gutjnl-2025-336027","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T08:26:06Z","timestamp":1764750366000},"score":1,"resource":{"primary":{"URL":"https:\/\/gut.bmj.com\/lookup\/doi\/10.1136\/gutjnl-2025-336027"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,5]]},"references-count":245,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2025,10,8]]},"published-print":{"date-parts":[[2025,11]]}},"alternative-id":["10.1136\/gutjnl-2025-336027"],"URL":"https:\/\/doi.org\/10.1136\/gutjnl-2025-336027","relation":{},"ISSN":["0017-5749","1468-3288"],"issn-type":[{"value":"0017-5749","type":"print"},{"value":"1468-3288","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,5]]}}}